The Trump administration is holding off on its threatened 100 percent tariffs on drugmakers that aren't building facilities in the U.S., with officials saying the new tax is still being prepared.

President Trump said on his Truth Social platform last week that, "Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product," unless the drugmaker is in the process of building a manufacturing plant in the U.S.

This announcement gave companies less than a week to prepare for a significant added tax on their imported products. Supply chain experts were left scratching their heads over the mechanics of how this policy would be enforced.

With the federal government shut down, it's unclear whether the necessary federal employees are on the job

See Full Page